Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph phase_1
4
100%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

recruiting375%
not_yet_recruiting125%

Recent Activity

3 active trials
Showing 4 of 4
recruitingphase_1

Gene Therapy for DME

NCT06492876
recruitingphase_1

Gene Therapy(FT-003) for Wet AMD

NCT06492863
recruitingphase_1

Gene Therapy for Diabetic Macular Edema

NCT05916391
not_yet_recruitingphase_1

Gene Therapy for Wet AMD

NCT05611424

Clinical Trials (4)

Showing 4 of 4 trials
NCT06492876Phase 1

Gene Therapy for DME

Recruiting
NCT06492863Phase 1

Gene Therapy(FT-003) for Wet AMD

Recruiting
NCT05916391Phase 1

Gene Therapy for Diabetic Macular Edema

Recruiting
NCT05611424Phase 1

Gene Therapy for Wet AMD

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
4